Glomerulonephritis Overview

Save information for later
Sign Up

Learn About Glomerulonephritis

What is the definition of Glomerulonephritis?
Glomerulonephritis is a type of kidney disease in which there is inflammation of the glomeruli, the tiny filters that remove excess waste and fluids from the blood. It may be acute or chronic (coming on gradually), and may occur on its own (primary) or be caused by another condition (secondary). Signs and symptoms may depend on the type and cause of the condition and may include blood in the urine; foamy urine; swelling of the face, eyes, or other body parts; abdominal pain; high blood pressure; fatigue; and/or other symptoms. If the condition is severe or prolonged, the kidneys can become damaged. It may be caused by a variety of infections and diseases, and sometimes the cause is unknown.
What are the alternative names for Glomerulonephritis?
  • Glomerulonephritis
  • Bright's disease
Who are the top Glomerulonephritis Local Doctors?
Elite in Glomerulonephritis
Dr. Tripti Singh
Nephrology
Elite in Glomerulonephritis
Dr. Tripti Singh
Nephrology

University Of Wisconsin Medical Foundation Inc

2977 County Hwy Cx, 
Portage, WI 
608-742-3004
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Tripti Singh is a Nephrologist in Portage, Wisconsin. Dr. Singh is rated as an Elite provider by MediFind in the treatment of Glomerulonephritis. Her top areas of expertise are Glomerulonephritis, Chronic Kidney Disease, Lupus Nephritis, End-Stage Renal Disease (ESRD), and Kidney Transplant. Dr. Singh is currently accepting new patients.

Dafna D. Gladman
Elite in Glomerulonephritis
Dafna D. Gladman
Elite in Glomerulonephritis
Dafna D. Gladman
399 Bathurst Street, 
Toronto, ON, CA 

Dafna Gladman practices in Toronto, Canada. Ms. Gladman is rated as an Elite expert by MediFind in the treatment of Glomerulonephritis. Her top areas of expertise are Psoriatic Arthritis, Psoriasis, Arthritis, Systemic Lupus Erythematosus (SLE), and Kidney Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Kenar D. Jhaveri
Elite in Glomerulonephritis
Dr. Kenar D. Jhaveri
Nephrology
Elite in Glomerulonephritis
Dr. Kenar D. Jhaveri
Nephrology

Northwell Health Physician Partners Kidney And Hypertension Specialists At Great Neck

100 Community Drive, 2nd Floor, 
Great Neck, NY 
516-465-8200
Languages Spoken:
English, Gujarati , Hindi
See accepted insurances
Offers Telehealth

"Kenar D. Jhaveri, MD, is Professor of Medicine and Associate Chief in the Division of Kidney Diseases and Hypertension at Northwell Health and Zucker School of Medicine at Hofstra/Northwell. He completed his residency training at Yale University New Haven Hospital in Internal Medicine and then a fellowship in Nephrology at New York Presbyterian Hospital-Weill Cornell campus. His clinical interests are in glomerular diseases and onconephrology( cancer and its effect on the kidney). He is the founding member of the American Society of Onconephrology. He is a columnist for the ASN Kidney News for the section called ""Detective Nephron."" His interest in nephrology education is vested in using creative ways of teaching nephrology to medical students. Dr. Jhaveri is rated as an Elite provider by MediFind in the treatment of Glomerulonephritis. His top areas of expertise are Glomerulonephritis, Interstitial Nephritis, Low Potassium Level, Low Sodium Level, and Kidney Transplant.

View All Doctors
What are the latest Glomerulonephritis Clinical Trials?
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis
Enrollment Status: Recruiting
Publish Date: October 15, 2025
Intervention Type: Drug
Study Phase: Phase 2

Background: Focal segmental glomerulosclerosis (FSGS) is a disease that causes scarring in parts of the kidneys that filter waste. This can lead to protein loss in the urine, which can worsen kidney function. The kidneys may fail over time, and dialysis or a kidney transplant may be needed. Other treatments for this disease do not always work and often have adverse effects. Better treatments for FSGS are need...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1920 in Adult Participants With PMN (Primary Membranous Nephropathy) Who Are at a High Risk for Disease Progression
A Phase 2a, Randomized, Double-blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of ALXN1920 in Adult Participants With PMN (Primary Membranous Nephropathy) Who Are at a High Risk for Disease Progression
Enrollment Status: Recruiting
Publish Date: October 15, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: The primary objective of this study is to evaluate the efficacy of ALXN1920 compared with placebo in participants with PMN who are at a high risk for disease progression using 24-hour urine protein creatinine ratio (UPCR).

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center